- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 215/50 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
Patent holdings for IPC class C07D 215/50
Total number of patents in this class: 105
10-year publication summary
|
2
|
8
|
1
|
6
|
5
|
6
|
3
|
15
|
10
|
6
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| HMI Medical Innovations, LLC | 14 |
8 |
| Bayer AG | 3562 |
7 |
| Bayer Pharma AG | 1009 |
5 |
| Taisho Pharmaceutical Co., Ltd. | 847 |
5 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3014 |
5 |
| Intervet International B.V. | 1337 |
3 |
| Bayer Cropscience AG | 1836 |
2 |
| Incyte Corporation | 1061 |
2 |
| Intervet Inc. | 932 |
2 |
| The Trustees of Princeton University | 1272 |
2 |
| UCB Biopharma SPRL | 331 |
2 |
| Wyeth | 167 |
2 |
| Disarm Therapeutics, Inc. | 56 |
2 |
| Kayothera, Inc. | 13 |
2 |
| Shandong Yuanlitai Medical Technology Co., Ltd. | 4 |
2 |
| Codagen Biosciences, Inc. | 5 |
2 |
| Novartis AG | 10175 |
1 |
| Bristol-myers Squibb Company | 4764 |
1 |
| F. Hoffmann-La Roche AG | 7800 |
1 |
| Hoffmann-La Roche Inc. | 3825 |
1 |
| Other owners | 48 |